Report Detail
Global Vinblastinesulphate (CAS 143-67-9) Market Growth 2019-2024
- RnM3072159 |
- 07 March, 2019 |
- Global |
- 135 Pages |
- LPI(LP Information) |
- Other
Vinblastinesulphate is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
Periwinkle Plantation is mainly concentrated in China. The production volume was high during 2000s, with a kilo of Vinca alkaloids can be sold at 10 USD/gram. Now as the less plantation in Hainan Province, the cost of Periwinkle and Vinca alkaloids has hiked at 20 USD/ gram. Currenly there are less companies produce Vinca alkaloids, since many companies couldn’t survive after capital chain breaks. Globally, leading suppliers are Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology and Guangzhou Person Pharmaceutical which are located in China. The three companies produced nealy 60% of global Vinblastinesulphate Vinkem from India also produce Vinblastinesulphate API for cancer treatment drugs.
According to this study, over the next five years the Vinblastinesulphate (CAS 143-67-9) market will register a 1.6% CAGR in terms of revenue, the global market size will reach US$ 21 million by 2024, from US$ 19 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Vinblastinesulphate (CAS 143-67-9) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Vinblastinesulphate (CAS 143-67-9) market by product type, application, key manufacturers and key regions and countries.
This study considers the Vinblastinesulphate (CAS 143-67-9) value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
>98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Vinblastinesulphate (CAS 143-67-9) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Vinblastinesulphate (CAS 143-67-9) market by identifying its various subsegments.
Focuses on the key global Vinblastinesulphate (CAS 143-67-9) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vinblastinesulphate (CAS 143-67-9) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Vinblastinesulphate (CAS 143-67-9) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Vinblastinesulphate (CAS 143-67-9) Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Vinblastinesulphate (CAS 143-67-9) Consumption 2014-2024
- 2.1.2 Vinblastinesulphate (CAS 143-67-9) Consumption CAGR by Region
- 2.2 Vinblastinesulphate (CAS 143-67-9) Segment by Type
- 2.2.1 >98% Vinblastinesulphate
- 2.2.2 97-98% Vinblastinesulphate
- 2.2.3 Other
- 2.3 Vinblastinesulphate (CAS 143-67-9) Consumption by Type
- 2.3.1 Global Vinblastinesulphate (CAS 143-67-9) Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Vinblastinesulphate (CAS 143-67-9) Sale Price by Type (2014-2019)
- 2.4 Vinblastinesulphate (CAS 143-67-9) Segment by Application
- 2.4.1 Lymphoma
- 2.4.2 Lung Cancer
- 2.4.3 Breast & Ovarian Cancer
- 2.4.4 Leukemia
- 2.4.5 Other
- 2.5 Vinblastinesulphate (CAS 143-67-9) Consumption by Application
- 2.5.1 Global Vinblastinesulphate (CAS 143-67-9) Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Vinblastinesulphate (CAS 143-67-9) Value and Market Share by Application (2014-2019)
- 2.5.3 Global Vinblastinesulphate (CAS 143-67-9) Sale Price by Application (2014-2019)
3 Global Vinblastinesulphate (CAS 143-67-9) by Players
- 3.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Players
- 3.1.1 Global Vinblastinesulphate (CAS 143-67-9) Sales by Players (2017-2019)
- 3.1.2 Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Players (2017-2019)
- 3.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Players
- 3.2.1 Global Vinblastinesulphate (CAS 143-67-9) Revenue by Players (2017-2019)
- 3.2.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Players (2017-2019)
- 3.3 Global Vinblastinesulphate (CAS 143-67-9) Sale Price by Players
- 3.4 Global Vinblastinesulphate (CAS 143-67-9) Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Vinblastinesulphate (CAS 143-67-9) Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Vinblastinesulphate (CAS 143-67-9) Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Vinblastinesulphate (CAS 143-67-9) by Regions
- 4.1 Vinblastinesulphate (CAS 143-67-9) by Regions
- 4.1.1 Global Vinblastinesulphate (CAS 143-67-9) Consumption by Regions
- 4.1.2 Global Vinblastinesulphate (CAS 143-67-9) Value by Regions
- 4.2 Americas Vinblastinesulphate (CAS 143-67-9) Consumption Growth
- 4.3 APAC Vinblastinesulphate (CAS 143-67-9) Consumption Growth
- 4.4 Europe Vinblastinesulphate (CAS 143-67-9) Consumption Growth
- 4.5 Middle East & Africa Vinblastinesulphate (CAS 143-67-9) Consumption Growth
5 Americas
- 5.1 Americas Vinblastinesulphate (CAS 143-67-9) Consumption by Countries
- 5.1.1 Americas Vinblastinesulphate (CAS 143-67-9) Consumption by Countries (2014-2019)
- 5.1.2 Americas Vinblastinesulphate (CAS 143-67-9) Value by Countries (2014-2019)
- 5.2 Americas Vinblastinesulphate (CAS 143-67-9) Consumption by Type
- 5.3 Americas Vinblastinesulphate (CAS 143-67-9) Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Vinblastinesulphate (CAS 143-67-9) Consumption by Countries
- 6.1.1 APAC Vinblastinesulphate (CAS 143-67-9) Consumption by Countries (2014-2019)
- 6.1.2 APAC Vinblastinesulphate (CAS 143-67-9) Value by Countries (2014-2019)
- 6.2 APAC Vinblastinesulphate (CAS 143-67-9) Consumption by Type
- 6.3 APAC Vinblastinesulphate (CAS 143-67-9) Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Vinblastinesulphate (CAS 143-67-9) by Countries
- 7.1.1 Europe Vinblastinesulphate (CAS 143-67-9) Consumption by Countries (2014-2019)
- 7.1.2 Europe Vinblastinesulphate (CAS 143-67-9) Value by Countries (2014-2019)
- 7.2 Europe Vinblastinesulphate (CAS 143-67-9) Consumption by Type
- 7.3 Europe Vinblastinesulphate (CAS 143-67-9) Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Vinblastinesulphate (CAS 143-67-9) by Countries
- 8.1.1 Middle East & Africa Vinblastinesulphate (CAS 143-67-9) Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Vinblastinesulphate (CAS 143-67-9) Value by Countries (2014-2019)
- 8.2 Middle East & Africa Vinblastinesulphate (CAS 143-67-9) Consumption by Type
- 8.3 Middle East & Africa Vinblastinesulphate (CAS 143-67-9) Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Vinblastinesulphate (CAS 143-67-9) Distributors
- 10.3 Vinblastinesulphate (CAS 143-67-9) Customer
11 Global Vinblastinesulphate (CAS 143-67-9) Market Forecast
- 11.1 Global Vinblastinesulphate (CAS 143-67-9) Consumption Forecast (2019-2024)
- 11.2 Global Vinblastinesulphate (CAS 143-67-9) Forecast by Regions
- 11.2.1 Global Vinblastinesulphate (CAS 143-67-9) Forecast by Regions (2019-2024)
- 11.2.2 Global Vinblastinesulphate (CAS 143-67-9) Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Vinblastinesulphate (CAS 143-67-9) Forecast by Type
- 11.8 Global Vinblastinesulphate (CAS 143-67-9) Forecast by Application
12 Key Players Analysis
- 12.1 Guangzhou Hanfang Pharmaceutical
- 12.1.1 Company Details
- 12.1.2 Vinblastinesulphate (CAS 143-67-9) Product Offered
- 12.1.3 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Guangzhou Hanfang Pharmaceutical News
- 12.2 Hainan Vinca Biological Medicine Technology
- 12.2.1 Company Details
- 12.2.2 Vinblastinesulphate (CAS 143-67-9) Product Offered
- 12.2.3 Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Hainan Vinca Biological Medicine Technology News
- 12.3 Guangzhou Person Pharmaceutical
- 12.3.1 Company Details
- 12.3.2 Vinblastinesulphate (CAS 143-67-9) Product Offered
- 12.3.3 Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Guangzhou Person Pharmaceutical News
- 12.4 Hainan Yueyang Biotechnology
- 12.4.1 Company Details
- 12.4.2 Vinblastinesulphate (CAS 143-67-9) Product Offered
- 12.4.3 Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Hainan Yueyang Biotechnology News
- 12.5 Hubei Honch Pharmaceutical
- 12.5.1 Company Details
- 12.5.2 Vinblastinesulphate (CAS 143-67-9) Product Offered
- 12.5.3 Hubei Honch Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Hubei Honch Pharmaceutical News
- 12.6 Fine Chemicals Corporation
- 12.6.1 Company Details
- 12.6.2 Vinblastinesulphate (CAS 143-67-9) Product Offered
- 12.6.3 Fine Chemicals Corporation Vinblastinesulphate (CAS 143-67-9) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Fine Chemicals Corporation News
- 12.7 Hengtengfu Biological Products
- 12.7.1 Company Details
- 12.7.2 Vinblastinesulphate (CAS 143-67-9) Product Offered
- 12.7.3 Hengtengfu Biological Products Vinblastinesulphate (CAS 143-67-9) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Hengtengfu Biological Products News
- 12.8 Vinkem
- 12.8.1 Company Details
- 12.8.2 Vinblastinesulphate (CAS 143-67-9) Product Offered
- 12.8.3 Vinkem Vinblastinesulphate (CAS 143-67-9) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Vinkem News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Vinblastinesulphate (CAS 143-67-9). Industry analysis & Market Report on Vinblastinesulphate (CAS 143-67-9) is a syndicated market report, published as Global Vinblastinesulphate (CAS 143-67-9) Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Vinblastinesulphate (CAS 143-67-9) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
